Suppr超能文献

高同型半胱氨酸血症诱导血管内皮功能障碍的机制-可能是磷脂酰肌醇-3-激酶及其下游磷酸肌醇依赖性激酶和蛋白激酶 B 的失调。

Mechanism of hyperhomocysteinemia-induced vascular endothelium dysfunction - possible dysregulation of phosphatidylinositol-3-kinase and its downstream phosphoinositide dependent kinase and protein kinase B.

机构信息

Department of Pharmacology, I.S.F. College of Pharmacy, G.T. Road, Moga 142001, Punjab, India.

出版信息

Eur J Pharmacol. 2013 Dec 5;721(1-3):365-72. doi: 10.1016/j.ejphar.2013.08.028. Epub 2013 Sep 8.

Abstract

Imbalance of l-arginine/endothelial nitric oxide synthatase (eNOS) activity is the hallmark of vascular endothelium dysfunction. Hyperhomocysteinemia (Hhy) has been identified as a potential risk factor for vascular endothelium dysfunction that leads to cardiovascular disorders. Phosphatidylinositol-3 kinase (PI3K) is a ubiquitous enzyme involved in plethora of cell signaling including the endothelial cells and it has been reported that signaling through this enzyme and its downstream pathway viz phosphoinositide-dependent kinase (PDK)/protein kinase B (Akt) and eNOS is impaired in diseased conditions. Thus present study was designed to investigate the role of PI3K and PDK/Akt in vascular endothelium dysfunction produced by Hhy. Hhy was produced by administering l-methionine (1.7%w/w, p.o). After four weeks of l-methionine administration, vascular endothelium dysfunction was assessed in terms of attenuation of acetylcholine-induced endothelium dependent relaxation (Isolated aortic ring preparation), a decrease in serum nitrite level, mRNA expression of eNOS (rtPCR) and disruption of integrity of vascular endothelium (Electron microscopy). Administration of insulin (0.6 IU/kg/day, s.c), YS-49 (1.6 mg/kg/day, i.p), DAQB1 (5mg/kg/day, i.p) and atorvastatin (30 mg/kg/day, p.o) significantly improved acetylcholine-induced endothelium-dependent relaxation, serum nitrate/nitrite level, mRNA expression of eNOS and integrity of vascular endothelium. This ameliorative effect of insulin was blocked by wortmannin (inhibitor of PI3K), UCN-01(PDK inhibitor), API-2 (Akt inhibitor) and l-NAME (eNOS inhibitor). Thus, it may be concluded that activation of PI3K and its downstream pathways viz. PDK/Akt and eNOS improve Hhy-induced vascular endothelium dysfunction and that therapeutic interventions designed for these pathways may provide potential therapeutic strategies to combat vascular complications.

摘要

精氨酸/内皮型一氧化氮合酶(eNOS)活性失衡是血管内皮功能障碍的标志。高同型半胱氨酸血症(Hhy)已被确定为血管内皮功能障碍的潜在危险因素,可导致心血管疾病。磷酸肌醇-3 激酶(PI3K)是一种广泛存在的酶,参与包括内皮细胞在内的多种细胞信号转导,据报道,在疾病状态下,通过这种酶及其下游途径(即磷酸肌醇依赖性激酶(PDK)/蛋白激酶 B(Akt)和 eNOS)的信号转导受损。因此,本研究旨在探讨 PI3K 和 PDK/Akt 在 Hhy 引起的血管内皮功能障碍中的作用。通过给予 L-蛋氨酸(1.7%w/w,口服)来产生 Hhy。在给予 L-蛋氨酸 4 周后,通过乙酰胆碱诱导的内皮依赖性舒张减弱(分离的主动脉环制备)、血清硝酸盐水平降低、eNOS 的 mRNA 表达(rtPCR)和血管内皮完整性破坏(电子显微镜)来评估血管内皮功能障碍。胰岛素(0.6 IU/kg/天,皮下注射)、YS-49(1.6 mg/kg/天,腹腔注射)、DAQB1(5mg/kg/天,腹腔注射)和阿托伐他汀(30 mg/kg/天,口服)的给药显著改善了乙酰胆碱诱导的内皮依赖性舒张、血清硝酸盐/亚硝酸盐水平、eNOS 的 mRNA 表达和血管内皮的完整性。胰岛素的这种改善作用被wortmannin(PI3K 抑制剂)、UCN-01(PDK 抑制剂)、API-2(Akt 抑制剂)和 l-NAME(eNOS 抑制剂)阻断。因此,可以得出结论,PI3K 的激活及其下游途径(即 PDK/Akt 和 eNOS)可改善 Hhy 诱导的血管内皮功能障碍,针对这些途径的治疗干预可能为对抗血管并发症提供潜在的治疗策略。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验